CN107151260A - 一种抗肿瘤活性化合物的制备方法 - Google Patents

一种抗肿瘤活性化合物的制备方法 Download PDF

Info

Publication number
CN107151260A
CN107151260A CN201710524848.8A CN201710524848A CN107151260A CN 107151260 A CN107151260 A CN 107151260A CN 201710524848 A CN201710524848 A CN 201710524848A CN 107151260 A CN107151260 A CN 107151260A
Authority
CN
China
Prior art keywords
methanol
natural products
dichloromethane
preparation
glucose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201710524848.8A
Other languages
English (en)
Other versions
CN107151260B (zh
Inventor
李法辉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daohe Weifang Pharmaceutical Technology Co ltd
Shandong Daohe Pharmaceutical Co ltd
Weifang Hongnuo Hetai New Material Science And Technology Co ltd
Weifang Medical University
Original Assignee
Weifang Hong Connaught And New Mstar Technology Ltd
Dongying Dao Yi Biological Medicine Science And Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Weifang Hong Connaught And New Mstar Technology Ltd, Dongying Dao Yi Biological Medicine Science And Technology Co Ltd filed Critical Weifang Hong Connaught And New Mstar Technology Ltd
Priority to CN201710524848.8A priority Critical patent/CN107151260B/zh
Publication of CN107151260A publication Critical patent/CN107151260A/zh
Application granted granted Critical
Publication of CN107151260B publication Critical patent/CN107151260B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/203Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • C07H1/06Separation; Purification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)

Abstract

本发明涉及一种抗肿瘤活性化合物的制备方法,属于药物化学领域。本发明以商品化的全乙酰化的葡萄糖为起始原料,以二氯甲烷为溶剂,在三氟化硼乙醚催化作用下,与3,4‑二甲氧基苯酚反应形成葡萄糖异头碳位置取代的糖苷中间体,接着在甲醇钠的碱性条件下脱除乙酰基,与全苄基保护的无水没食子酸制得的苯甲酰氯进行区域选择性的化学反应,得到关键的糖基中间体,最后经钯碳还原脱除苄基保护,以简洁高效的4步反应,高产率地形成糖苷类天然产物1,制备的该种糖苷类天然产物具有很好的肿瘤细胞毒活性。

Description

一种抗肿瘤活性化合物的制备方法
技术领域
本发明涉及药物化学领域,具体涉及一种抗肿瘤活性化合物的制备方法。
背景技术
糖类化合物与氨基酸、萜类等是构建手性化合物的天然手性原料,广泛应用于许多天然活性手性化合物的合成或催化剂及手性助剂的制备。含有D-葡萄糖片段的活性天然产物在自然界中分布广泛,此类化合物在生物学及药学方面具有重要的意义,但是用于合成此类化合物的原料D-葡萄糖,现有的合成方法比较复杂,从而导致商业化价格较高。因此研究一种糖苷类天然产物的制备及其在活性天然产物方面的应用,具有重要的应用价值。
发明内容
本发明的目的是提供一种糖苷类天然产物的制备方法,它可以作为手性原料用于其它活性优异化合物的合成或进行含有D-葡萄糖片段的天然产物的合成。
本发明以便宜易得的D-葡萄糖为起始原料,以简洁高效的5步反应,高产率的形成下述结构的糖苷类天然产物1:
上述结构1的一种糖苷类天然产物通过下述方法制备,
(1)称取35.0-40.0g全乙酰化保护的葡萄糖、3-5g三乙胺、20.0-23.0g 3,4-二甲氧基苯酚,依次加入200-300mL二氯甲烷中,0℃条件下,分批加入50-60g催化剂。自然升至室温反应9小时,依次用饱和碳酸氢钠、饱和食盐水洗涤,过滤,浓缩,用无水甲醇重结晶得白色固体化合物,得到葡萄糖异头碳位置取代的糖苷中间体;
(2)称取5.0-10g步骤(1)中得到的葡萄糖异头碳位置取代的糖苷中间体,溶解于140-280mL干燥的甲醇中,加入25﹪的甲醇钠溶液1-2mL,加热至25℃,反应1.5小时,加入阳离子交换树脂,至反应液PH值6,搅拌1小时,过滤,减压浓缩滤液,即可得到脱除乙酰基保护的葡萄糖异头碳位置取代的糖苷中间体,所得产物用甲醇、乙酸乙酯、二氯甲烷重结晶;
(3)称取2.0-3.0g步骤(2)中得到的除乙酰基保护的葡萄糖异头碳位置取代的糖苷中间体溶解于280-350mL无水吡啶中,低温条件下分批加入羟基全苄基保护的无水没食子酸制得的苯甲酰氯2.9-4.5g,加热升至35℃反应12小时,加入甲醇终止反应,减压浓缩,硅胶柱层析得到糖基伯羟基位取代的中间体,所述层析溶剂为二氯甲烷和甲醇,二氯甲烷:甲醇=100:1-80:1;
(4)将步骤(3)中得到糖基伯羟基位取代的中间体溶解于150-200mL乙酸乙酯:甲醇=2:1的混合溶液中,加入还原剂,25℃条件下反应10小时,减压浓缩,硅胶柱层析得到该种糖苷类天然产物1,所述层析溶剂为二氯甲烷和甲醇,二氯甲烷:甲醇=25:1。
优选的,所述的催化剂为三氟化硼乙醚硅胶.。
优选的,所述的催化剂的当量数为0.5~3。
优选的,低温条件为:-10℃到-40℃
优选的,所述的还原剂为:20%Pd-C。
本发明制得的一种糖苷类天然产物1还可用于制备其它活性优异化合物。
本发明的一种糖苷类天然产物的合成路线,制备方法简单,反应条件易于控制,收率高,分离简便,可作为最初原料用于其它活性优异化合物的合成。
具体实施方式
本发明的一种糖苷类天然产物1的制备方法,包括以下步骤:
(1)称取步骤(1)中得到的羟基乙酰化保护的葡萄糖中间体(35g,89.7mmol),三乙胺(4.75g,46.9mmol)、3,4-二甲氧基苯酚(20g,129.7mmol),依次加入二氯甲烷(250mL)中,0℃条件下,分批加入三氟化硼乙醚硅胶(50g),然后自然升至室温反应9小时;然后有机相依次用饱和碳酸氢钠、饱和食盐水洗涤,过滤,浓缩,用无水甲醇重结晶,得到40.95g葡萄糖异头碳位置取代的糖苷中间体,产率94.3%。
(2)称取步骤(1)中得到的葡萄糖异头碳位置取代的糖苷中间体(5.0g,10.3mmol),溶解于干燥的甲醇(140mL)中,加入25﹪的甲醇钠(1mL),加热至25℃,反应1.5小时,加入阳离子交换树脂调节PH值至6,搅拌1小时,过滤,减压浓缩滤液,得到的固体用甲醇、乙酸乙酯、二氯甲烷重结晶,即可得到3.05g脱除乙酰基保护的葡萄糖异头碳位置取代的糖苷中间体,产率93.8%。
(3)称取步骤(2)中得到的脱除乙酰基保护的葡萄糖异头碳位置取代的糖苷中间体(2.0g,6.3mmol)溶解于无水吡啶(280mL)中,-15℃条件下分批加入自制的羟基全苄基保护的无水没食子酸制得的苯甲酰氯(2.9g,6.3mmol),加热升至室温反应12小时,加入甲醇终止反应,减压浓缩,硅胶柱层析(二氯甲烷:甲醇=100:1-80:1)得到4.47g糖基伯羟基位取代的中间体,产率96.1%。
(4)将步骤(3)中得到糖基伯羟基位取代的中间体(2.2g,3mmol)溶解于乙酸乙酯:甲醇=2:3的混合溶液(150m)L中,加入20﹪的Pd/C(370mg),25℃条件下反应10小时,减压浓缩,硅胶柱层析(二氯甲烷:甲醇=25:1)得到该种糖苷类天然产物1的白色固体1.28g,产率91.3%。

Claims (6)

1.一种糖苷类天然产物1的制备方法,其特征在于,其包括下述步骤:
(1)称取35.0-40.0g全乙酰化保护的葡萄糖、3-5g三乙胺、20.0-23.0g 3,4-二甲氧基苯酚,依次加入200-300mL二氯甲烷中,0℃条件下,分批加入50-60g催化剂。自然升至室温反应9小时,依次用饱和碳酸氢钠、饱和食盐水洗涤,过滤,浓缩,用无水甲醇重结晶得白色固体化合物,得到葡萄糖异头碳位置取代的糖苷中间体;
(2)称取5.0-10g步骤(1)中得到的葡萄糖异头碳位置取代的糖苷中间体,溶解于140-280mL干燥的甲醇中,加入25﹪的甲醇钠溶液1-2mL,加热至25℃,反应1.5小时,加入阳离子交换树脂,至反应液PH值6,搅拌1小时,过滤,减压浓缩滤液,即可得到脱除乙酰基保护的葡萄糖异头碳位置取代的糖苷中间体,所得产物用甲醇、乙酸乙酯、二氯甲烷重结晶;
(3)称取2.0-3.0g步骤(2)中得到的除乙酰基保护的葡萄糖异头碳位置取代的糖苷中间体溶解于280-350mL无水吡啶中,低温条件下分批加入羟基全苄基保护的无水没食子酸制得的苯甲酰氯2.9-4.5g,加热升至35℃反应12小时,加入甲醇终止反应,减压浓缩,硅胶柱层析得到糖基伯羟基位取代的中间体,所述层析溶剂为二氯甲烷和甲醇,二氯甲烷:甲醇=100:1-80:1;
(4)将步骤(3)中得到糖基伯羟基位取代的中间体溶解于150-200mL乙酸乙酯:甲醇=2:1的混合溶液中,加入还原剂,25℃条件下反应10小时,减压浓缩,硅胶柱层析得到该种糖苷类天然产物1,所述层析溶剂为二氯甲烷和甲醇,二氯甲烷:甲醇=25:1。
2.如权利要求1所述的该种糖苷类天然产物1的制备方法,其特征是,所述的步骤(1)中催化剂为三氟化硼乙醚硅胶。
3.如权利要求2所述的该种糖苷类天然产物1的制备方法,其特征是,所述的催化剂的当量数为0.5~3。
4.如权利要求3所述的该种糖苷类天然产物1的制备方法,其特征是,所述的步骤(3)中低温条件为:-10℃到-40℃。
5.如权利要求4所述的种糖苷类天然产物1的制备方法,其特征是,步骤(4)中所述的还原剂为:20%Pd-C。
6.如权利要求1-5任一权利要求所述的糖苷类天然产物1在制备其它活性优异化合物中的应用。
CN201710524848.8A 2017-06-30 2017-06-30 一种抗肿瘤活性化合物的制备方法 Active CN107151260B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710524848.8A CN107151260B (zh) 2017-06-30 2017-06-30 一种抗肿瘤活性化合物的制备方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710524848.8A CN107151260B (zh) 2017-06-30 2017-06-30 一种抗肿瘤活性化合物的制备方法

Publications (2)

Publication Number Publication Date
CN107151260A true CN107151260A (zh) 2017-09-12
CN107151260B CN107151260B (zh) 2020-09-15

Family

ID=59795113

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710524848.8A Active CN107151260B (zh) 2017-06-30 2017-06-30 一种抗肿瘤活性化合物的制备方法

Country Status (1)

Country Link
CN (1) CN107151260B (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108929857A (zh) * 2017-05-26 2018-12-04 中国海洋大学 一种柳珊瑚来源的海洋真菌及其在制备拓扑异构酶i抑制剂中的应用

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
SAGAR D. NALE,等: ""Synthesis of tyrosyl-DNA phosphodiesterase I inhibitors"", 《TETRAHEDRON LETTERS》 *
李化军: ""3-取代槲皮素衍生物的合成研究"", 《中国优秀博硕士学位论文全文数据库(硕士)医药卫生科技辑》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108929857A (zh) * 2017-05-26 2018-12-04 中国海洋大学 一种柳珊瑚来源的海洋真菌及其在制备拓扑异构酶i抑制剂中的应用
CN108929857B (zh) * 2017-05-26 2021-10-29 中国海洋大学 一种柳珊瑚来源的海洋真菌及其在制备拓扑异构酶i抑制剂中的应用

Also Published As

Publication number Publication date
CN107151260B (zh) 2020-09-15

Similar Documents

Publication Publication Date Title
CN102276673B (zh) 一种2-脱氧-β-D-吡喃葡萄糖基三唑类化合物的制备方法
JP4856071B2 (ja) 20(S)−ジンセノサイドRh2の合成方法
EP3227309A1 (en) Crystalline difucosyllactose
CN104045669B (zh) 一种适合工业化生产的化学合成红景天苷的分离方法
US4683297A (en) Process for the preparation of glycosides
CN107151260A (zh) 一种抗肿瘤活性化合物的制备方法
KR100508724B1 (ko) 트레할로오스및당알코올의제조방법
CN103539827B (zh) 一种合成对甲氧基三苯基α-S-(1→6)-D-葡萄二糖的方法
CN104961787B (zh) 一种虫草素的合成方法
JP2008137982A (ja) 高純度マルチトール結晶性粉末を調製するためのプロセス
CN100494216C (zh) 20(s)-原人参二醇糖基化衍生物及其制备方法和应用
JPH0331294A (ja) 新規なオリゴ糖及びその製造方法
Åberg et al. Large scale synthesis of two trisaccharide spacer glycosides corresponding to the blood group A and B determinants using thioglycosides and dimethyl (thiomethyl) sulfonium tetrafluoroborate (DMTSB) as promoter
CA2104476A1 (en) New and improved solvent-free synthesis of ethereally substituted blocked monosaccharides and the selective hydrolysis_thereof
Kishida et al. Chemoenzymatic synthesis of n-hexyl and O-β-D-xylopyranosyl-(1→ 6)-β-D-glucopyranosides
JP5569877B2 (ja) キチンオリゴ糖誘導体及びn−アセチルラクトサミン誘導体並びにそれらの製造方法
CN109422783A (zh) 一种化学合成红景天苷的方法
FI59241C (fi) Kristallisering av xylitol i vattenloesning
CN107056849B (zh) 一种全乙酰基保护α-2,6-二脱氧葡萄糖-O-糖苷的制备方法
CN114736315B (zh) 香菇多糖核心片段β-(1→6)支链β-(1→3)主链的七糖合成方法
CN115073541A (zh) 一种合成甘油葡萄糖苷及其衍生物的方法
CN105330704A (zh) 2-脱氧-d-葡萄糖的制备方法
JPS63215688A (ja) フェノ−ル配糖体の製造法
CN114835766A (zh) 一种从二元混合物中分离l-岩藻糖的方法
JPH024229B2 (zh)

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
CB02 Change of applicant information

Address after: 257093 Binhai New District, Lijin County, Dongying City, Shandong Province (Diaokou Township Residence)

Applicant after: SHANDONG DOYE PHARMACEUTICAL TECHNOLOGY Co.,Ltd.

Applicant after: WEIFANG HONGNUO HETAI NEW MATERIAL SCIENCE AND TECHNOLOGY Co.,Ltd.

Address before: 257093 Binhai New District, Lijin County, Dongying City, Shandong Province (Diaokou Township Residence)

Applicant before: DONGYING DAOYI BIOLOGICAL MEDICINE TECHNOLOGY Co.,Ltd.

Applicant before: WEIFANG HONGNUO HETAI NEW MATERIAL SCIENCE AND TECHNOLOGY Co.,Ltd.

CB02 Change of applicant information
TA01 Transfer of patent application right

Effective date of registration: 20200812

Address after: 261053 Shandong city of Weifang province Baotong Street No. 7166

Applicant after: WEIFANG MEDICAL University

Applicant after: SHANDONG DOYE PHARMACEUTICAL TECHNOLOGY Co.,Ltd.

Applicant after: Shandong Daozhen Pharmaceutical Technology Co.,Ltd.

Applicant after: WEIFANG HONGNUO HETAI NEW MATERIAL SCIENCE AND TECHNOLOGY Co.,Ltd.

Address before: Dongying City, Shandong province 257093 Binhai Lijin County (diaokouhe Township resident)

Applicant before: SHANDONG DOYE PHARMACEUTICAL TECHNOLOGY Co.,Ltd.

Applicant before: WEIFANG HONGNUO HETAI NEW MATERIAL SCIENCE AND TECHNOLOGY Co.,Ltd.

TA01 Transfer of patent application right
GR01 Patent grant
GR01 Patent grant
PE01 Entry into force of the registration of the contract for pledge of patent right
PE01 Entry into force of the registration of the contract for pledge of patent right

Denomination of invention: A preparation method of antitumor compound

Effective date of registration: 20210224

Granted publication date: 20200915

Pledgee: Industrial and Commercial Bank of China Limited Shouguang sub branch

Pledgor: Shandong Daozhen Pharmaceutical Technology Co.,Ltd.

Registration number: Y2021980001298

CP01 Change in the name or title of a patent holder

Address after: 261053 No. 7166 Baotong West Street, Weifang City, Shandong Province

Patentee after: WEIFANG MEDICAL University

Patentee after: Shandong Daohe Pharmaceutical Co.,Ltd.

Patentee after: Daohe (Weifang) Pharmaceutical Technology Co.,Ltd.

Patentee after: WEIFANG HONGNUO HETAI NEW MATERIAL SCIENCE AND TECHNOLOGY Co.,Ltd.

Address before: 261053 No. 7166 Baotong West Street, Weifang City, Shandong Province

Patentee before: WEIFANG MEDICAL University

Patentee before: SHANDONG DOYE PHARMACEUTICAL TECHNOLOGY Co.,Ltd.

Patentee before: Shandong Daozhen Pharmaceutical Technology Co.,Ltd.

Patentee before: WEIFANG HONGNUO HETAI NEW MATERIAL SCIENCE AND TECHNOLOGY Co.,Ltd.

CP01 Change in the name or title of a patent holder
PC01 Cancellation of the registration of the contract for pledge of patent right

Date of cancellation: 20211124

Granted publication date: 20200915

Pledgee: Industrial and Commercial Bank of China Limited Shouguang sub branch

Pledgor: Shandong Daozhen Pharmaceutical Technology Co.,Ltd.

Registration number: Y2021980001298

PC01 Cancellation of the registration of the contract for pledge of patent right
PE01 Entry into force of the registration of the contract for pledge of patent right

Denomination of invention: A preparation method of antitumor active compound

Effective date of registration: 20211126

Granted publication date: 20200915

Pledgee: Industrial and Commercial Bank of China Limited Shouguang sub branch

Pledgor: Daohe (Weifang) Pharmaceutical Technology Co.,Ltd.

Registration number: Y2021980013408

PE01 Entry into force of the registration of the contract for pledge of patent right
PC01 Cancellation of the registration of the contract for pledge of patent right

Date of cancellation: 20221019

Granted publication date: 20200915

Pledgee: Industrial and Commercial Bank of China Limited Shouguang sub branch

Pledgor: Daohe (Weifang) Pharmaceutical Technology Co.,Ltd.

Registration number: Y2021980013408

PC01 Cancellation of the registration of the contract for pledge of patent right
EE01 Entry into force of recordation of patent licensing contract

Application publication date: 20170912

Assignee: Shandong Xindao Pharmaceutical Technology Co.,Ltd.

Assignor: Shandong Daohe Pharmaceutical Co.,Ltd.

Contract record no.: X2022980019300

Denomination of invention: Preparation of an anti-tumor active compound

Granted publication date: 20200915

License type: Common License

Record date: 20221024

EE01 Entry into force of recordation of patent licensing contract